Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

The wrinkle in Valeant’s pursuit of Allergan Add to ...

Subscribers Only

The pursuit of Allergan Inc. is taking on a frantic air.

Perhaps that’s because Valeant Pharmaceuticals International Inc. sees huge untapped value in the Botox maker. More likely, though, it’s because the strategy that has turned the Canadian drug peddler into a stock market superstar is reaching its natural limit.

Report Typo/Error

Follow on Twitter: @IanMcGugan

Next story

loading

In the know

The Globe Recommends

loading

Most popular videos »

Highlights

More from The Globe and Mail

Most popular